DB05333ExperimentalSmall molecule
TC-5231 is a small molecule that has been under investigation as an oral treatment for ADHD (Attention Deficit/Hyperactivity Disorder). TC-5231 is mecamylamine hydrochloride, the active ingredient in FDA-approved product, Inversine,...
- Primary indication
- Investigated for use/treatment in attention deficit/hyperactivity disorder (ADHD), neurologic disorders, and tourette's syndrome.Curator reviewed
- Code names
- TC-5231
Which companies are running trials of TC-5231, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account